Latest Nursing research Stories
NEW YORK, Nov. 19, 2012 /PRNewswire/ -- New York City-based Ai Cure Technologies opened the Innovation Showcase at CNS Summit in Boca Raton, Fla, with a presentation of its flagship digital health solution, AiView(TM). The interactive computer-vision software makes use of the webcam on a smartphone or tablet computer to automatically monitor medication adherence in clinical trials and ongoing care settings. (Logo: http://photos.prnewswire.com/prnh/20121119/NY16060LOGO) Clinical...
Researchers report at American Society of Human Genetics 2012 meeting A consortium of scientists who are taking a novel approach in their research to detect the genetic variations that predispose individuals to type 2 diabetes provided an update of their findings at the American Society of Human Genetics (ASHG) 2012 meeting. Among the project's novel characteristics is the ethnic diversity of the 10,000 individuals whose exomes, the 18,000 protein-coding genes, are being sequenced....
( ) VALENCIA, Calif., Nov. 7, 2012 /PRNewswire/ -- Sanguine BioSciences, Inc., a biotechnology company providing transparency to patients in biomedical research, has named Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to its Clinical Advisory Board and Ethics Committee. Ms. Rosario's extensive experience in clinical development and human ethics in clinical trials qualifies her to be the first to join Sanguine's Clinical Advisory Board and Ethics...
Computational medicine, a fast-growing method of using computer models and sophisticated software to figure out how disease develops–and how to thwart it–has begun to leap off the drawing board and land in the hands of doctors who treat patients for heart ailments, cancer and other illnesses. Using digital tools, researchers have begun to use experimental and clinical data to build models that can unravel complex medical mysteries. These are some of the conclusions of a new review of...
BOTHELL, WA and VANCOUVER, BC, Oct. 30, 2012 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's third quarter 2012 financial results will be released on Thursday, November 8, 2012, and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon. Management will discuss the company's financial results and provide an update on clinical development programs for custirsen and OGX-427. To access the...
Workshop First in Series to Engage Patients and Broader Healthcare Community in Refining PCORI's Research Agenda WASHINGTON, Oct. 24, 2012 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) will bring patients, caregivers, researchers and other healthcare stakeholders together this coming weekend in a workshop designed to start building a patient-centered research community. The workshop, "Transforming Patient- Centered Research: Building...
Leading clinicians and health researchers from across Europe say much greater emphasis must be placed on the scientific evidence for the effectiveness of treatments and other healthcare interventions to ensure patients receive the best care available. The call is contained in a Science Policy Briefing published by the European Medical Research Councils, which also made ten key recommendations on how to improve the quality of research and healthcare in Europe. The briefing,...
ELLICOTT CITY, Md., Oct. 15, 2012 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) was unveiled during the 7(th) Annual Site Solutions Summit on October 13, 2012. SCRS was founded in response to the growing need for a trade organization to represent the voice of clinical research sites within the clinical research enterprise. The Society's mission is to Unify and amplify the voice of the global clinical research site community. Christine Pierre, founder...
NASHVILLE, Tenn., Oct. 11, 2012 /PRNewswire/ -- Cumberland Emerging Technologies, Inc. (CET) today announced that three tenants at its Nashville Life Sciences Center have been awarded $3.2 million in federal small business grants. The grantees, which include Jericho Sciences LLC, and a research alliance comprised of Cumberland Pharmaceuticals Inc., CET, and the University of Virginia, will use the funding to support their work in developing new medical therapies. Jericho Sciences LLC...
Improved study design and data sharing are expected to speed therapy development A workshop sponsored by NIH's National Institute of Neurological Disorders and Stroke (NINDS) has produced a set of consensus recommendations to improve the design and reporting of animal studies. By making animal studies easier to replicate and interpret, the workshop recommendations are expected to help funnel promising therapies to patients. Biomedical research involving animals has led to life-saving...
